DVHPDI: Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative

Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT02021838
Collaborator
Michigan State University (Other)
666
1
84
7.9

Study Details

Study Description

Brief Summary

In collaboration with the National Institute of Justice (NIJ) and the Office for Violence Against Women (OVW) the Yale University team will evaluate the implementation process and impact of the U.S. Department of Justice's Domestic Violence Homicide Prevention Demonstration Initiative. This evaluation seeks to draw critical findings and potential lessons from the combined experience of the sites including: 1) how the models work in different communities; 2) the barriers and facilitators to implementing the models; and 3) outcomes of the model delivery. The evaluation team will also disseminate the findings with the goal of informing replication.

Condition or Disease Intervention/Treatment Phase
  • Other: Lethality Assessment Program
  • Other: Domestic Violence High Risk Team

Detailed Description

Process Evaluation: The process evaluation will assess: 1) the training and technical assistance provided to sites; 2) the implementation of the models in the communities; and 3) characteristics of the service delivery systems.

Technical Assistance Providers will document the training and technical assistance (TTA) they provide to the sites.

Sites will be asked to identify key stakeholders to participate in interviews before the implementation begins and then two additional times during the demonstration phase. Key informant interviews will assess: recipient's perception of the training and technical assistance; model fidelity; model implementation (including model penetration, barriers and facilitators to implementation); and, perceptions of model impact. In addition to key informant interviews administrative data will be gathered to assess aspects of model implementation and systematic observations of law enforcement initiated screens will be conducted by a member of the evaluation team who will join patrol officers for "ride-alongs".

Impact Evaluation: The impact evaluation will assess changes in: 1) collaboration among service sectors; 2) supervision and sanctions for offenders; 3) recidivism and re-victimization; 4) victim reported feelings of safety; 5) utilization of resources; and 6) nature of safety planning.

System Collaboration will be assessed through a web-based survey completed at three time points by key stakeholders representing all potential partners in the community. Social network analysis will provide a visual depiction of how the network changes over time.

Victim Interviews will be conducted to determine the impact of involvement in the model program on their safety and wellbeing. Victims will be interviewed at three time points and will be asked about: prior and recent contact with law enforcement, domestic violence service providers or other providers; awareness of resources to address IPV; their safety and fear of their partner; coping strategies utilized; social support; financial resources; willingness to utilize criminal justice system and domestic violence service providers; both their and offenders behavior, beliefs and attitudes; self-reported mental health and substance abuse; their report of offenders substance abuse; and demographic information.

Administrative Data will be utilized to examine the breadth of the model implementation; the impact of the model programs on criminal justice processes; and whether there is a connection between the extent of post-risk assessment sanctions and services and the pattern of newly recorded incidents between the victim and offender. The evaluation will compare processing and outcomes across cases that are in many ways similar except that some cases were determined to be high risk and a risk assessment was completed and others where a risk assessment was not conducted. To facilitate these comparisons, the evaluation team will build a comprehensive database that will depict the "life-history" of each victim and offender dyad.

Study Design

Study Type:
Observational
Actual Enrollment :
666 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the Domestic Violence Homicide Prevention Initiative
Actual Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
California

Lethality Assessment Program

Other: Lethality Assessment Program
Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
Other Names:
  • LAP
  • North Carolina

    Lethality Assessment Program

    Other: Lethality Assessment Program
    Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
    Other Names:
  • LAP
  • Ohio

    Domestic Violence High Risk Team

    Other: Domestic Violence High Risk Team
    Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services and a team who monitors the clinical and criminal justice progress.
    Other Names:
  • HRT
  • Illinois

    Lethality Assessment Program

    Other: Lethality Assessment Program
    Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
    Other Names:
  • LAP
  • Michigan

    Lethality Assessment Program

    Other: Lethality Assessment Program
    Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
    Other Names:
  • LAP
  • Tennessee

    Lethality Assessment Program

    Other: Lethality Assessment Program
    Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.
    Other Names:
  • LAP
  • Outcome Measures

    Primary Outcome Measures

    1. Decreased frequency of re-assault [up to 3 years]

      Decrease in harassment, assault, injury, homicide/mortality

    Secondary Outcome Measures

    1. Increased collaboration between network partners [up to 3 years]

      Increased information sharing, case planning, coordinated response

    2. Increased awareness of and utilization of resources for victims [Up to 3 years]

      Increased awareness of and utilization of community resources

    3. Increased safety planning [Up to 3 years]

      Increased safety planning at the time of police intervention

    4. Increased victim reported safety [Up to 3 years]

      Victim reported changes in perceptions of safety

    5. Increased sanctions for offender [Up to 3 years]

      Sanctions such as pre-trial containment, cases to trial, adjudications, containment post-adjudication

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    The demonstration sites are:

    California North Carolina Ohio Illinois Michigan Tennessee

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Yale University New Haven Connecticut United States 06511

    Sponsors and Collaborators

    • Yale University
    • Michigan State University

    Investigators

    • Principal Investigator: Joy S Kaufman, PhD, Yale University
    • Study Director: Christopher Maxwell, PhD, Michigan State University
    • Study Director: Tami Sullivan, PhD, Yale University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yale University
    ClinicalTrials.gov Identifier:
    NCT02021838
    Other Study ID Numbers:
    • 1311013010
    First Posted:
    Dec 27, 2013
    Last Update Posted:
    Mar 24, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Yale University

    Study Results

    No Results Posted as of Mar 24, 2021